ArticleNeuro-oncology2014

Impact of meriolins, a new class of cyclin-dependent kinase inhibitors, on malignant glioma proliferation and neo-angiogenesis.

Marie Jarry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.